Suvorexant
4 NDCs across 1 manufacturer|0 Generic,4 Brand
Suvorexant is used to treat sleep initiation and maintenance disorders, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 13, 2014. In 2024, Medicare Part D spent $150 million on Suvorexant across 315,000 claims for 77,000 beneficiaries.
Suvorexant is available as 4 NDCs from 1 manufacturer (0 generic, 4 brand), with NADAC prices from $15.19 to $15.21 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
0G / 4B
Manufacturers
1
competing in market
Price Spread
$15.19 – $15.21
per EA
7d Activity
avg -0.0% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Merck Sharp & Dohme LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Orexin Receptor Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing SUVOREXANT
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BELSOMRA 10 MG TABLET | $15.2127 per EA | +0.02% |
BELSOMRA 20 MG TABLET | $15.2053 per EA | -0.01% |
BELSOMRA 5 MG TABLET | $15.2013 per EA | -0.08% |
BELSOMRA 15 MG TABLET | $15.1906 per EA | -0.05% |
Frequently Asked Questions
What is Suvorexant used to treat?
Suvorexant is used to treat sleep initiation and maintenance disorders, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Suvorexant?
In 2024, Medicare Part D spent $150 million on Suvorexant across 315,000 claims for 77,000 beneficiaries.
How many Suvorexant products are on the market?
The Suvorexant drug market contains 4 NDCs from 1 manufacturer — 0 generic and 4 brand products.
What is the price range for Suvorexant?
NADAC reference prices for Suvorexant range from $15.1906 to $15.2127 per EA — a 0% difference between cheapest and most expensive.
Which manufacturers make Suvorexant?
1 manufacturer lists Suvorexant in NADAC. Ranked by number of NDCs, the largest are Merck Sharp & Dohme LLC (4).
How has the price of Suvorexant changed recently?
Over the past 7 days, 1 Suvorexant NDC rose and 3 fell, with a market-wide average change of -0.0%.